Stem Cells & Regenerative Medicine

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Stem Cells & Regenerative Medicine

Stem Cell Research Price: $4,750.00 (€3,719.10) ($5,700.00 (€4,462.92) Including VAT at 20%) Publication Date: Jan-2012 Format: PDF Pages: 750 Publisher: RI Technologies Table of Contents Sample Pages This report on Stem Cell Research gives a market insight into the ever progressing and debatable market of Stem Cell Research segmented by type, technology and therapeutic area. Stem Cells by Type are further classified into Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells and Other. Stem Cell Research by Technology is segmented into Stem Cell Transplantation, CB Genomics, Xenotransplantation, Cord Blood Banking and Other. The Therapeutic applications of Stem Cell Research are analyzed by area into Neurology, Orthopedics, Oncology, Hematology, Cardiology, Dermatology, Diabetes, Hepatology and Other. Projections and estimates are graphically illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 58 major companies are discussed in the report. The report serves as a guide to global Stem Cell industry covering more 640 companies that are engaged in stem cell R&D, storage, banking, discovery, testing and supply of products and services. The report also gives a comprehensive global list of 200+ cord blood/stem cell banks. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Compilation of Worldwide Patents and Research related to Stem Cell Research is also provided.

Stem Cell Research in Cardiology Price: $4,300.00 (€3,366.77) ($5,160.00 (€4,040.12) Including VAT at 20%) Publication Date: Jan-2012 Format: PDF Pages: 315 Publisher: RI Technologies Table of Contents Sample Pages This market insight report on Stem Cell Research in Cardiology emphasizes on the market for stem cells in Cardiology. The study is segmented by Source (Allogenic and Autogenic) and by Type (Bone Marrow Stem Cells, Embryonic Stem Cells, and Other). Estimations and Predictions for 2005-2015 are graphically illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 17 major companies are discussed in the report. The text is complemented by 26 exhibits. The report serves as a guide to global market for Stem Cells in Cardiology covering more than 230 companies that are engaged in stem cell R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Compilation of Worldwide Patents and Research related to Stem Cell Research in Cardiology is also provided. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report.

Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 22-Nov-2011 Format: PDF Pages: 160 Publisher: GBI Research More...

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2012 Please click here for more information or to purchase this report at our partner store Published: January 2012 Pages: 122 This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields. In this report, we focus upon the biology of CTCs and CSCs as well as explore the inter-relationship between these cell types based upon molecular events. Also presented are research trends which are for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastatic mechanisms.

Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009-2015 Price Single User $4,710.00 Enterprise Wide $6,510.00 Publication Date: May-2011 Format: PDF Pages: 692 Publisher: Axis Research Mind Report Brochure Report Description and Table of Contents

Cryopreservation Equipments in Stem Cells - A Global Market Watch, 2009-2015 Price Single User $3,540.00 Enterprise Wide $5,330.00 Publication Date: May-2011 Format: PDF Pages: 531 Publisher: Axis Research Mind Report Brochure Report Description and Table of Contents

Single Cell Omics 2011 Please click here for more information or to purchase this report at our partner store Published: May 2011 Pages: 167 The single cell Omics revolution is the potential transformation of cellular heterogeneity from a source of noise to a source of new, as yet hidden discoveries. No longer will the variability from one cell to the next confound researchers and force them to average results into irrelevance. Researchers may find, in fact, that this variability is critical for cells to respond to and interact with their environments. But even without the complete revolution, single cell Omics offer significant evolutionary advances in fields of biology and medicine that are already based on single cell analysis, such as immunology, neurobiology, stem cell biology, circulating tumor cells and preimplantation genetic diagnosis. Moreover, the ongoing evolution of single cell Omics technologies provides improvements in sensitivity and throughput that will enable researchers to generate more data from smaller numbers of cells, which can be enabling in cases of precious samples. The result of this (r)evolution is a market for Omics technologies that is projected to grow from $60 million in sales in 2010 to $525 million in 2016, according to Single Cell Omics 2011, a new report published by Select Biosciences and written by BioPerspectives.

Future Directions in Regenerative Medicine Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%) Publication Date: 24-Feb-2011 Please click here for more information or to purchase this report at our partner store Big Pharma has begun investing in regenerative medicine: Genzyme in 2008, Pfizer and Novartis in 2009, and Cephalon in 2010. In 3-5 years, investment will reach a “tipping point”, after which no medical industry players will want to be left behind.

Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 10-Feb-2011 Format: PDF Pages: 100 Publisher: GBI Research More...

Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 30-Nov-2010 Format: PDF Pages: 7 Publisher: GlobalData More...

Adult Stem Cells Market Trends 2011 Please click here for more information or to purchase this report at our partner store Published: January 2011 Pages: 100 This is the latest and most up-to-date Market Report from Select Biosciences addressing the adult stem cells marketplace. In this report, we focus upon adult stem cells (especially mesenchymal stem cells; MSCs) and their properties making them highly suited for the development of cellular therapeutics.

Stem Cell Market: Opportunities and Challenges Price: $800.00 (€626.38) ($960.00 (€751.65) Including VAT at 20%) Publication Date: 01-Dec-2010 Format: PDF Email Pages: 44 Publisher: Koncept Analytics Stem cell biology is a promising and emerging field of the life sciences. Advances in biological sciences and the development of human stem cells are bringing new hope for the treatment of many diseases such as Parkinson’s disease, diabetes, heart diseases and cancer as well as injuries for which there has previously been no effective treatment. The medical stem cells market is divided into three categories: stem cell therapeutics, cord blood banking and drug development tools based on the application. Stem cell therapeutics account for a major portion of the market which has been boosted by recent technological breakthroughs that expanded the scope of therapeutic uses. North America is the largest market for stem cells for 2009 with a share of slightly over one-third of global market while Europe is projected to be the second largest and second fastest growing market. US is the major stem cell market in the world and has recently been boosted by the decision on lifting the 8 years old ban on federal funding for embryonic stem cell research on March 2009. Despite of the technological and ethical challenges surrounding the utilization of embryonic stem cells, recent developments to grow human embryonic stem cells in culture and an increased understanding of the pathways of cell differentiation have expanded the horizon of likely therapeutic uses. In addition, rising patient population, demand for umbilical cord cell banking and transplantation have increased the demand for stem cells development. The current report covers the overview, market size and segmentation of the worldwide stem cell product market. The US market for stem cells is also discussed in detail. The various drivers and the challenges faced by the market are also discussed in detail. The competitive aspect of the market is also highlighted and the key players are profiled with their strategies for this market. Table of Contents/List of Tables/List of Figures

Stem Cells Market And Applications. 2009-2015 Price Single User $4,773.00 Enterprise Wide $6,123.00 Publication Date: 07-Aug-2010 Format: pdf Pages: 468 Publisher: Axis Research Mind Report Brochure Table of Contents The 'Stem Cells Market and Applications, 2009-2015' reviews the latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. More...

Stem Cells Market And Technologies, 2009-2015 Price Single User $4,350.00 Enterprise Wide $5,700.00 Publication Date: 07-Aug-2010 Format: pdf Pages: 472 Publisher: Axis Research Mind Report Brochure Table of Contents The 'Stem Cells Market and Technologies, 2009-2015' reviews the latest trends in the stem cells market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science and healthcare sector investments. The study reveals profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. More...

Stem Cells Market And Drug Discovery Applications, 2009-2015 Price Single User $3,783.00 Enterprise Wide $5,133.00 Publication Date: 07-Aug-2010 Format: pdf Pages: 410 Publisher: Axis Research Mind Report Brochure Table of Contents The 'Stem Cells Market and Drug Discovery Applications, 2009-2015' reviews latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. More...

Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 01-Feb-2010 Format: PDF Pages: 77 Publisher: GBI Research More...

Stem Cell-Based Therapeutic Delivery: Challenges & Opportunities Price: $1,432.00 (€1,121.21) ($1,718.40 (€1,345.45) Including VAT at 20%) Published: 15/12/2008 Pages: 180 Format: PDF Publisher: Pharmavision This cutting edge & insightful report can be used to interpret & assess the potential of stem cell-based medicines. It provides opinions & market projections to: • assess the commercial potential of stem cell-based therapies in all of the key therapeutic areas: autoimmune diseases, cardiovascular, CNS & hematological malignancies; • identify key pharma & delivery specialists advancing the next generation of regenerative medicines; • gain an in-depth understanding of the technological manufacturing & delivery issues which face companies developing stem cell-based therapies; • evaluate the options available for delivering stem cell-based therapies now & in the future; • discover which companies are tackling the technological hurdles & are in a prime position to exploit new opportunities; • analyzes how the market will evolve over the next decade highlighting key trends, opportunities & challenges. Full Details Sample Pages

Global Stem Cell and Advanced Technologies Market Price Single User (+$4,650.00) Multi User (+$5,650.00) Corporate Licence (+$7,150.00) Enterprise Site Licence (+$9,000.00) Published: 11/1/2009 Pages: 229 Format: pdf Author: MarketsandMarkets Table of Contents The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth. The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron. More...

Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine Please click here for more information or to purchase this report at our partner store This market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010. The data presented herein are based on primary market surveys from a worldwide respondent pool of industry participants active in the stem cells field. This bottom-up analysis highlights market trends operative and enables the identification of trends vis-a-vis the research marketplace, utilization of different classes of stem cells, as well as the penetrance of different research product vendors into specific segments of the stem cells marketplace. This market report is built using data and analyses from Select Biosciences continual industry tracking of this marketplace and our analysis of this space provides up-to-date qualitative and quantitative market metrics. Primary Market Data Provide a Comprehensive and Bottom-Up Picture of the marketplace for the utilization of stem cells for drug discovery/toxicity screening efforts as well as research for regenerative medicine applications.

Adult Stem Cells and iPSCs 2010 Please click here for more information or to purchase this report at our partner store This market report from Select Biosciences comprehensively addresses the technology and market landscape governing adult stem cells as well as induced pluripotent stem cells (iPSCs). Adult stem cells currently underlie the majority of cellular therapeutics that are under development worldwide and this market report maps this landscape with particular emphasis on the characteristics of adult stem cells which leverage their utilization for cellular therapy/regenerative medicine. This market report is built using data and analyses from Select Biosciences continual industry tracking of this marketplace and our deep analysis of this space provides up-to-date qualitative and quantitative market metrics. Primary Market Data Provide a Comprehensive and Bottom-Up Picture of the Space for Adult Stem Cells as wells as for iPSCs. In this market report, we provide a technical, market (global research trends), intellectual property, and a regulatory map of the iPSC space that is granular and up-to-date.

Single Cell Analysis 2010: the New Frontier for 'Omics Please click here for more information or to purchase this report at our partner store ’Omics has unleashed a deluge of data that underscores the complexity of biological systems. Simplification and specificity is the new dogma, and one of the most promising approaches is single cell analysis. No longer are large groups of cells containing high and low responders, early and late responders and fast and slow responders averaged into oblivion. ’Omics technologies are beginning to be used to analyze genes, proteins, and metabolites in single cells, and beginning to meet the significant demand in applications such as cancer biology, stem cell biology, neurobiology, synthetic biology and biofuel and drug development, where understanding and manipulating the full complexity of intracellular pathways is the Holy Grail. ’Omics-based single cell analysis is a new market opportunity with potential growth that is almost beyond belief. The market is projected to grow from $70 million in sales in 2009 to more than $575 million in 2015, according to Single Cell Analysis 2010: the New Frontier for ’Omics, a new report published by Select Biosciences and written by BioPerspectives.

Stem Cells for Cellular Therapy 2010 Please click here for more information or to purchase this report at our partner store This is the latest and most up-to-date Market Report from Select Biosciences addressing the cellular therapy space. Select Biosciences’ industry coverage of the stem cells space is broad and comprehensive—each segment of the space is therefore analyzed and presented in detail in a market report. This market report is focused on presenting the market characteristics of stem cells as they are currently impacting research in the cellular therapy space. Furthermore, this report also addresses an important market, namely that of Umbilical Cord Blood Banking.

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Stem Cells & Regenerative Medicine